Alert
In This Section

Available Tests

  • Respiratory Pathogen Panel with COVID

Respiratory Pathogen Panel with COVID

Includes: ADENOVIRUS
SARS-COV-2
NON-COVID CORONAVIRUSES
INFLUENZA A/B VIRUSES
METAPNEUMOVIRUS
RHINOVIRUS/ENTEROVIRUS
RESPIRATORY SYNCYTIAL VIRUS (RSV)
PARAINFLUENZA VIRUSES 1-4
Bordetella parapertussis*
Bordetella pertussis*

Mycoplasma pneumoniae
Chlamydia pneumoniae
*Bordetella sp. only tested on NP Swabs
Test ID LAB5812
EPIC Order
RESPIRATORY PATHOGEN PANEL WITH COVID
CPT Code(s) 0100U
Group/Individual Test Group
Laboratory Molecular Microbiology; 984-974-1820
Tube Station 82
Specimen Routine:
Nasopharyngeal swabs, Oropharnygeal (OP) swabs, NP/OP swabs, nasopharyngeal(NP) aspirates, bronchoalveolar lavages, bronchial washings, expectorated and induced sputa, and tracheal aspirates. Specimens must be transported to the Microbiology laboratory as soon as possible, but no later than 2 hours post-collection.
See collection video if needed.
NOTE: For the most sensitive detection of Bordetella pertussis/parapertussis, the Bordatella pertussis/parapertussis PCR test should be ordered on an NP Swab.
Availability Routine: 24/7
Turnaround Time Routine:
4 hours
Comments
Test Information for Providers
Test Information for Patients

Testing performed using the BioFire FilmArray Respiratory Panel 2.1 assay which has been validated by the CLIA-certified, CAP-inspected UNC Medical Center Clinical Molecular Microbiology Laboratory. FDA has granted Emergency Use Authorization for this test as it includes detection of SARS-CoV-2 RNA by targeting the S and M genes. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. Ct (cycle threshold) values for SARS-CoV-2 are not available for this test.  

This assay does not distinguish between rhinovirus and enterovirus. Lower respiratory specimens will not be tested for Bordetella pertussis/parapertussis. For nasopharyngeal swabs, cross-reactivity may occur between B. pertussis and non-pertussis Bordetella species. All positive B. pertussis results will be automatically confirmed using our in-house PCR assay for confirmation

Reviewed by Christopher Parker on January 27, 2021

Note: Reference ranges provided on this web site are for guidance only, and may not reflect the most recent changes. Refer to laboratory reports for current reference data.

UNC Hospitals
McLendon Clinical Laboratories
101 Manning Drive
Chapel Hill, NC 27514